Moreover, the 36-month beta value for ENTX is 1.59. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ENTX is 28.36M and currently, short sellers hold a 0.32% of that float. On May 07, 2024, ENTX’s average trading volume was 246.17K shares.
ENTX) stock’s latest price update
The stock of Entera Bio Ltd (NASDAQ: ENTX) has increased by 10.65 when compared to last closing price of 2.16.Despite this, the company has seen a gain of 18.91% in its stock price over the last five trading days. Zacks Investment Research reported 2024-04-26 that The latest trading day saw Entera Bio Ltd. (ENTX) settling at $1.98, representing a -1% change from its previous close.
ENTX’s Market Performance
ENTX’s stock has risen by 18.91% in the past week, with a monthly rise of 20.40% and a quarterly rise of 218.67%. The volatility ratio for the week is 10.18% while the volatility levels for the last 30 days are 14.66% for Entera Bio Ltd The simple moving average for the past 20 days is 8.96% for ENTX’s stock, with a 139.29% simple moving average for the past 200 days.
Analysts’ Opinion of ENTX
Many brokerage firms have already submitted their reports for ENTX stocks, with Aegis Capital repeating the rating for ENTX by listing it as a “Buy.” The predicted price for ENTX in the upcoming period, according to Aegis Capital is $12 based on the research report published on March 22, 2021 of the previous year 2021.
ENTX Trading at 34.39% from the 50-Day Moving Average
After a stumble in the market that brought ENTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -28.66% of loss for the given period.
Volatility was left at 14.66%, however, over the last 30 days, the volatility rate increased by 10.18%, as shares surge +22.56% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +127.62% upper at present.
During the last 5 trading sessions, ENTX rose by +18.91%, which changed the moving average for the period of 200-days by +182.84% in comparison to the 20-day moving average, which settled at $2.22. In addition, Entera Bio Ltd saw 298.33% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ENTX starting from Taitel Haya, who purchase 9,500 shares at the price of $0.99 back on Jan 12 ’24. After this action, Taitel Haya now owns 35,115 shares of Entera Bio Ltd, valued at $9,405 using the latest closing price.
Taitel Haya, the Director of Entera Bio Ltd, purchase 7,615 shares at $0.77 during a trade that took place back on Jan 10 ’24, which means that Taitel Haya is holding 25,615 shares at $5,864 based on the most recent closing price.
Stock Fundamentals for ENTX
The total capital return value is set at -0.42. Equity return is now at value -80.30, with -71.42 for asset returns.
Based on Entera Bio Ltd (ENTX), the company’s capital structure generated 0.04 points at debt to capital in total, while cash flow to debt ratio is standing at -18.47. The debt to equity ratio resting at 0.04. The interest coverage ratio of the stock is 1.02.
Currently, EBITDA for the company is -8.88 million with net debt to EBITDA at 1.2. The liquidity ratio also appears to be rather interesting for investors as it stands at 10.32.
Conclusion
To wrap up, the performance of Entera Bio Ltd (ENTX) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
